Illumina Accelerator Invests in Seven Omics Startups Advancing Breakthrough Therapeutics, Diagnostics, DNA Storage, Mental Wellness, and Sustainable Foods Applications
Summary
"We are delighted to welcome our newest investments and are honored to partner with talented entrepreneurs around the world focused on unlocking the power of the genome to make an impact on human health and beyond." • NonExomics, Inc., a proteogenomics and AI-driven therapeutics company from and , is developing a proprietary platform to mine novel drug targets from the dark and uncharacterized regions of the genome. • Rethink Bio Private Limited, a synthetic biology company from , is focused on harnessing the potential of microalgae to develop sustainable food solutions to benefit the planet and people. "These seven new investments demonstrate the power of genomics to advance breakthrough discoveries across therapeutics, diagnostics, sustainable foods and direct to consumer applications to transform human health." Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets.
Classifications
AskAI Classifications
LabelsLinked Companies
